Document is current
Any future updates will be listed below
-
Authors
Looker, Katharine J. http://orcid.org/0000-0002-3375-0807
Booton, Ross http://orcid.org/0000-0002-3013-4179
Begum, Najida http://orcid.org/0000-0001-9186-8267
Beck, Ekkehard http://orcid.org/0000-0002-2022-9190
Shen, Jing http://orcid.org/0000-0002-7611-4173
Turner, Katherine M. E. http://orcid.org/0000-0002-8152-6017
Christensen, Hannah http://orcid.org/0000-0002-2388-9733
- License Information
-
More Information
Article History
Received: 30 August 2022
Accepted: 18 November 2022
First Online: 10 January 2023
Declarations
:
: Ethical approval was not required for this study, and patients and the public were not involved in this study.
: Not applicable.
: This work was supported by GlaxoSmithKline Biologicals SA. KJL reports grants from WHO paid to her employer outside the submitted work; NB is a freelance consultant for GSK and therefore received consulting fees during the conduct of the study; EB was an employee of GSK during the course of this study and holds shares in GSK; JS was an employee of GSK during the course of this study and holds shares in GSK; KMET reports that since the completion of this work she has changed position and has received payment to her current employer (Aquarius Population Health) for expert consultation in related projects including participation in an expert advisory board for GSK; HC reports honoraria from Sanofi-Pasteur, and consultancy fees from IMS Health and AstraZeneca all paid to her employer, and outside of the submitted work; RB does not declare any competing interests.
